Page last updated: 2024-11-02

piribedil and Autosomal Dominant Juvenile Parkinson Disease

piribedil has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 3 studies

Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lane, EL1
Dunnett, SB1
Boraud, T1
Bezard, E1
Bioulac, B1
Gross, CE1

Reviews

1 review available for piribedil and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
[Parkinson disease: diagnostic and therapeutic criteria].
    Presse medicale (Paris, France : 1983), 2001, Mar-03, Volume: 30, Issue:8

    Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis,

2001

Other Studies

2 other studies available for piribedil and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Pre-treatment with dopamine agonists influence L-dopa mediated rotations without affecting abnormal involuntary movements in the 6-OHDA lesioned rat.
    Behavioural brain research, 2010, Nov-12, Volume: 213, Issue:1

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Corpus Striatum; Dopamine Agonists; Dyskinesia, Drug-I

2010
Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey.
    Brain : a journal of neurology, 2001, Volume: 124, Issue:Pt 3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzaze

2001